Affiliate disclosure
How this site earns, and the rules that keep it out of the evidence.
Which pages carry a link, and which do not
Two intervention pages — Fisetin and Quercetin — carry an affiliate link. 5 of the 7 intervention pages carry no link. The reason is recorded for each one.
| Fisetin | affiliate link present |
| Quercetin | affiliate link present |
| Dasatinib + Quercetin (D+Q) | This site provides no purchase link for D+Q, which includes the prescription oncology medicine dasatinib. |
| Navitoclax (ABT-263) | This site provides no purchase link for the experimental study compound navitoclax. |
| UBX0101 | This site offers no purchase link for the investigational study compound UBX0101. |
| Dasatinib | Prescription medicine. Not a supplement and not obtainable over the counter -- no purchase link on any page. |
| Genetic senescent-cell clearance (INK-ATTAC / p16 ablation) | A transgenic research model, not a therapeutic and not a product. |
The short version
Two intervention pages carry related retailer-search links. They do not establish retail-product equivalence to study material. Publisher Nabus AS may earn a commission on qualifying purchases. Nabus AS charges no fee for following these links; retailer prices and terms apply. The affiliate relationship is disclosed on the linked pages. Editorial decisions do not depend on advertiser approval.
What a link here is allowed to be
Linked pages distinguish the reported experimental exposures from a related retailer search. A search link does not identify or endorse the exact preparation used in a trial.
- No product is ranked, scored, or called the best one.
- No dose, protocol, or regimen is suggested anywhere on this site. Fisetin is a clear example: the displayed exposure describes a specific weight-based research protocol and does not establish equivalence to a retail preparation; this site does not tell you what to take.
- No brand comparison. Where a trial used specific material, the page says so because that is what was used — not as an endorsement.
- Prescription and investigational compounds carry no purchase link at all. Dasatinib, navitoclax and UBX0101 are never linked for purchase, and neither is the dasatinib+quercetin combination.
- No price appears next to a retailer link. The build fails if one does.
What a link is never allowed to change
The honesty flag, the five-qualifier claim, the species and endpoint labelling, and the negative or null findings are set by the record and by the methodology — never by whether a compound can be bought. Both linked compounds here have thin or contested human evidence, and the pages say so while the link sits on the same page. The linked human senolytic studies evaluated quercetin with dasatinib; they do not establish benefit from standalone retail quercetin. If that ever stops being true, this page is the one that was violated.
Programmes
Nabus AS, the publisher of SeneSIQ, uses Amazon affiliate links. As an Amazon Associate, Nabus AS earns from qualifying purchases. The publisher’s agreement register records an active Amazon account and historical use of the senesiq-20 tag; it does not document separate current domain approval. Any further programme will be named here before its first link is published.
What this does not change
SeneSIQ remains an educational reference. It does not diagnose, does not recommend treatment, and is not a substitute for a clinician — see the medical disclaimer. Nothing on this site should be read as a reason to take a supplement. The linked experimental exposures do not establish a routine treatment schedule.